This article is a correction to:
Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
Anup Bhusal
Md Habibur Rahman1†
In-Kyu Lee
Kyoungho Suk- 1BK21 Plus KNU Biomedical Convergence Program, Departments of Biomedical Science and Pharmacology, School of Medicine, Kyungpook National University, Daegu, South Korea
- 2Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea
- 3Brain Science and Engineering Institute, Kyungpook National University, Daegu, South Korea
A Corrigendum on
Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
by Bhusal, A., Rahman, M. H., Lee, I.-K., and Suk, K. (2019). Front. Endocrinol. 10:25. doi: 10.3389/fendo.2019.00025
In the original article, there was a mistake in Figure 1 as published. The Gapdh band image used in Figure 1C was from the pilot experiment. The corrected Figure 1 appears below.
FIGURE 1
Figure 1. Expression of LCN2 in the hippocampus of diabetic mice. The expression of Lcn2 mRNA in the hippocampus at 8 w post MLDS and 4 w post HDS injection was assessed by conventional PCR (A,C). Further, the expression level of LCN2 protein in the hippocampus of STZ-induced diabetic mice was estimated by ELISA assay (B,D). Similar upregulation of Lcn2 mRNA and LCN2 protein was detected in the hippocampus at 24 w post HFD feeding (E,F). *p < 0.05 vs. the vehicle-treated control animals; Student's t-test; n = 3 for each group; data are represented as mean ± SEM. STZ, streptozotocin; MLDS, multiple low dose of STZ; HDS, high dose of STZ; HFD, high fat diet; LCN2, Lipocalin-2; w, weeks; SEM, standard error of the mean.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Lipocalin-2, diabetic encephalopathy, hippocampus, glia, neuroinflammation, cognitive dysfunction
Citation: Bhusal A, Rahman MH, Lee I-K and Suk K (2019) Corrigendum: Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy. Front. Endocrinol. 10:239. doi: 10.3389/fendo.2019.00239
Received: 25 March 2019; Accepted: 26 March 2019;
Published: 09 April 2019.
Approved by: Frontiers in Endocrinology Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2019 Bhusal, Rahman, Lee and Suk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kyoungho Suk, ksuk@knu.ac.kr
†These authors have contributed equally to this work